Obstructive sleep apnea syndrome and erectile dysfunction: Does long term continuous positive airway pressure therapy improve erections?

Objectives: The aim of this age-matched, controlled, prospective clinical study was to investigate frequency and degree of erectile dysfunction (ED) in patients with obstructive sleep apnea syndrome (OSAS) and to evaluate the results of only continuous positive airway pressure (CPAP) therapy on ED in patients with OSAS. Materials and Methods: A total of 90 patients were evaluated for potential OSAS. They were given an International Index of Erectile Function questionnaire (IIEF) and Beck Depression Inventory. Sixty-two patients with the diagnosis of OSAS were regarded as study group. Twenty-eight patients in whom the OSAS was excluded, were regarded as the control group. Biochemical and hormonal laboratory evaluation were performed. Then all patients underwent a full-night in laboratory polysomnography examination. The degree of OSAS were evaluated by an expert from chest diseases department. Results: When compared to the control group, a decrease in IIEF-5 scores was found in patients with OSAS. However, this decrease was not statistically significant. After 3 months of CPAP usage in patients with mild to moderate and severe degree OSAS, improvement in IIEF-5 scores was statistically significant. Mean value of IIEF-5 score was 16.63±5.91 before CPAP and were improved up to 20.92±6.79 (P=0.001). Conclusion: It is not certainly possible to say that OSAS is clearly associated with ED. However, after 3 months of regular CPAP usage, ED complaints in patients with OSAS might improve positively. Trials with larger series may give more conclusive data. © 2015, Makerere University, Medical School. All rights reserved.

Yazar Husnu T.
Ersoz A.
Bulent E.
Tacettin O.
Remzi A.
Bulent A.
Aydin M.
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/6805
Tek Biçim Adres 10.4314/ahs.v15i1.23
Konu Başlıkları CPAP
Erectile dysfunction
Obstructive sleep apnea syndrome
Sleep disorder
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı African Health Sciences
Dergi Cilt Bilgisi 15
Dergi Sayısı 1
Sayfalar 171 - 179
Yayın Yılı 2015
Eser Adı
[dc.title]
Obstructive sleep apnea syndrome and erectile dysfunction: Does long term continuous positive airway pressure therapy improve erections?
Yazar
[dc.contributor.author]
Husnu T.
Yazar
[dc.contributor.author]
Ersoz A.
Yazar
[dc.contributor.author]
Bulent E.
Yazar
[dc.contributor.author]
Tacettin O.
Yazar
[dc.contributor.author]
Remzi A.
Yazar
[dc.contributor.author]
Bulent A.
Yazar
[dc.contributor.author]
Aydin M.
Yayın Yılı
[dc.date.issued]
2015
Yayıncı
[dc.publisher]
Makerere University, Medical School
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Objectives: The aim of this age-matched, controlled, prospective clinical study was to investigate frequency and degree of erectile dysfunction (ED) in patients with obstructive sleep apnea syndrome (OSAS) and to evaluate the results of only continuous positive airway pressure (CPAP) therapy on ED in patients with OSAS. Materials and Methods: A total of 90 patients were evaluated for potential OSAS. They were given an International Index of Erectile Function questionnaire (IIEF) and Beck Depression Inventory. Sixty-two patients with the diagnosis of OSAS were regarded as study group. Twenty-eight patients in whom the OSAS was excluded, were regarded as the control group. Biochemical and hormonal laboratory evaluation were performed. Then all patients underwent a full-night in laboratory polysomnography examination. The degree of OSAS were evaluated by an expert from chest diseases department. Results: When compared to the control group, a decrease in IIEF-5 scores was found in patients with OSAS. However, this decrease was not statistically significant. After 3 months of CPAP usage in patients with mild to moderate and severe degree OSAS, improvement in IIEF-5 scores was statistically significant. Mean value of IIEF-5 score was 16.63±5.91 before CPAP and were improved up to 20.92±6.79 (P=0.001). Conclusion: It is not certainly possible to say that OSAS is clearly associated with ED. However, after 3 months of regular CPAP usage, ED complaints in patients with OSAS might improve positively. Trials with larger series may give more conclusive data. © 2015, Makerere University, Medical School. All rights reserved.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
CPAP
Konu Başlıkları
[dc.subject]
Erectile dysfunction
Konu Başlıkları
[dc.subject]
Obstructive sleep apnea syndrome
Konu Başlıkları
[dc.subject]
Sleep disorder
Haklar
[dc.rights]
info:eu-repo/semantics/openAccess
ISSN
[dc.identifier.issn]
1680-6905
İlk Sayfa Sayısı
[dc.identifier.startpage]
171
Son Sayfa Sayısı
[dc.identifier.endpage]
179
Dergi Adı
[dc.relation.journal]
African Health Sciences
Dergi Sayısı
[dc.identifier.issue]
1
Dergi Cilt Bilgisi
[dc.identifier.volume]
15
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.4314/ahs.v15i1.23
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/6805
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
9
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
24 Şubat 2024 05:28
Google Kontrol
Tıklayınız
patients degree IIEF-5 regarded control laboratory evaluated decrease months statistically scores However significant improved before improvement moderate severe Objectives conclusive Makerere larger University Medical School rights reserved series Trials Conclusion compared possible clearly positively associated
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms